Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study
Wilson X. Wang, … , Jonathan J. Miner, Rajendra S. Apte
Wilson X. Wang, … , Jonathan J. Miner, Rajendra S. Apte
Published December 16, 2024
Citation Information: J Clin Invest. 2024;134(24):e189023. https://doi.org/10.1172/JCI189023.
View: Text | PDF | Amended Article
Corrigendum

Crizanlizumab for retinal vasculopathy with cerebral leukoencephalopathy in a phase II clinical study

Abstract

Authors

Wilson X. Wang, Dan Spiegelman, P. Kumar Rao, Rennie L. Rhee, Andria L. Ford, Jonathan J. Miner, Rajendra S. Apte

×

Download this citation for these citation managers:

Or, download this citation in these formats:

If you experience problems using these citation formats, send us feedback.
Advertisement